Member Info for KTRB

Lordy,, just if you needed a reminder to get in here! You can't help but be enthused by this guy,,, bring on the news and get this Acacia noise out of the way.

Released today
https://www.irishtimes.com/business/health-pharma/open-orphan-develops-first-challenge-study-model-to-test-covid-19-vaccines-1.4287166

Any estimate/educated guess on what volume is left?

In my view the testing will need to be ramped up in the workplace as responsibility will fall on the employers to provided a safe working environment. Recent outbreaks in Germany and Anglesey are an example of this. ORPH is obviously well placed for this testing with the focus on B2B. I still see the Covid Clear side of the business as a revenue side stream, with the jackpot focused on challenge trials for the ultimate vaccines being developed and our non Covid work. All my view though and I know little compared to some on here.

Deepjoy, you are spot on mate, these boards have become a communist propaganda machine, any question or comment that is even slightly negative will have the thought police jumping on you. I had the same with ODX some weeks back, I watched the Gov webinar for Covid testing and commented I heard the Chief Chip say the app and testing won't be ready until autumn, I got blasted for commenting on that, anyhow I sold out and look at that massacre now. This board wasn't like this to begin with but now it's full of thought police. Of course people DYOR but sometimes it's good to come here and read other views,,, if no one can say their views without these bell ends jumping on you, what's the point of these boards.

Are you ramping?

It's not even relevant is it? I believe their news is still related to PCR testing (have I got it), ORPH do not compete in this area? ORPH offer the Covid Clear testing (antibodies) and the vaccine challenge studies (plus the non Covid paths) - no relation whatsoever IMO?

What is the 500k left? The acacia shares?

Hardman & Co Research: Open Orphan presenting at virtual Investor Forum on 9th July 2020

We are delighted to announce that Open Orphan will be presenting at our next Investor Forum on Thursday 9th July. The Investor Forum connects investors with companies looking for capital. Each company will present for 10-15 minutes, followed by an opportunity for Q&A.

Open Orphan (ORPH) is a publicly traded company on the London AIM and Euronext Growth stock exchanges. The company was founded in 2017 with the aim of becoming a leading specialist CRO pharmaceutical services business. It has a focus on rare disease/orphan drugs, and is a world leader in the provision of virology and vaccine challenge study services and viral laboratory services. Open Orphan is comprised of two commercial specialist CRO services businesses, hVIVO and Venn Life Sciences; and has offices in London, Dublin, Paris and the Netherlands. The company consists of four elements: a European clinical research organisation and consultancy; an orphan drug services business; a Virtual Rep and Data Access Platform consisting of physicians and key opinion leaders; and a Health Data Platform to partner with Patient Advocacy Groups. It also provides digital data platforms to support companies in research & development and commercialisation.

https://www.hardmanandco.com/july-2020-virtual-investor-forum/

If you are interested in attending the virtual forum, you can register your interest by clicking on the above link.

If we finally offload the Acacia sell off and placing share movement, should we see some serious movement with the SP here?

Are we still churning here or do people think it's been cleared now?

Cheers Gents, appreciate it

This is worth a look also, when the Flu-V vaccine was at phase 2 progress the share price increased 57%, we are in phase 3 now :)

https://www.telegraph.co.uk/business/2018/06/18/hvivo-shares-soar-57pc-strikes-gold-universal-flu-vaccine/

I believe that ORPH will release this in an RNS, in earlier presentations CF has mentioned it and said there would be further news announced. Now it is in the Lancet, I do not see any reason why CF would not capitalise on the PR from this. Folk can whinge that there is no 'deal' or 'financials' involved as yet, but you cannot underestimate this news on the 'holy grail' of vaccines. Can you imagine big Pharma (GSK AZK etc) not capitalising on this news? All this news on this vaccine, Flu-v, now Covid with Prep Bio etc is huge, not to mention the challenge studies and mainstream testing. Amazing opportunity here for investment, really exciting.

It's like watching paint dry, I'll look again late next week once this offload is done,,, Cathal, do us a favour and please do not release any RNS on deals until this is over zzzzzzzzzzz

Si and Rudey, I'm in the same boat was you, cashed out of all holdings (as IMO the main market will go bang after Q2 results) and I'm in here with 462K of shares @13.7 avg. I am confident though, I see both medium and long term gains here and there is no guesswork or fantasies needed, the CEO is all in, he actively provides information, the deals are there to see, the potential is huge. The pro investor conservative target is 19p, even the garbage Motley Fool have a 30p target, to back my thinking up. If Imutex comes off (as I look to the heavens) the rewards are huge! Stay confident and good luck to us all. CF for El Presidente!!

Perhaps a cut and paste standard reply is needed for those that cannot read?

Out of the gate we have Venn with a Major contract,,, being chased by immediate cash from Qotient Covid testing and the challenge trials currently in third, three is a strong challenge by the Imutex deal, but wait what's this,,, its the Flu V vaccine chasing hard followed by the init malarial,,,, who will win?

And just like that they appear, good call mate!

Awesome, as CF said deals will be coming thick and fast in the coming weeks,,,, great news and well done ORPH